Watch Ticker

INmune Bio Inc. Common stock

Go to INmune Bio Inc. Common stock Website

$2.44

0.04 (1.67%)

Live

Previous Close

$2.4

Day Range

$2.29 - $2.43

Previous Day Range

$2.375 - $2.551

Market Cap

$65.4 million USD

Day Vol.

769500

Previous Day Vol.

756167

Currency

USD

Primary Exchange

Nasdaq

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Inmune Bio Inc. - INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th

INmune Bio Inc. will host a conference call on August 7th, 2025 at 4:30pm EDT to discuss Q2 2025 financial results and provide a corporate update, focusing on their clinical-stage inflammation and immunology research.

Related tickers: INMB.

Read Full Article

Inmune Bio Inc. - INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

INmune Bio will host a conference call on June 30, 2025, to present top line data from their Phase 2 MINDFuL trial investigating XPro™ treatment for early Alzheimer's Disease, focusing on patients with mild cognitive impairment and neuroinflammation markers.

Related tickers: INMB.

Read Full Article

Trending Tickers

Please sign in to view